drugset / Trial / NCT06720025
Study of SAL-0951 Compared to Recombinant Human Erythropoietin in Anemic Patients Receiving Maintenance Hemodialysis
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of SAL-0951 in Chinese patients undergoing maintenance hemodialysis with chronic kidney disease and anemia，who are receiving stable treatment with erythropoietic stimulants (ESAs).
Timeline
- Start
- 2023-09-19
- Primary completion
- 2024-06-17
- Completion
- 2024-06-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SAL-0951 | Unknown | 1 mg | — |
| Subject | SAL-0951 | Unknown | 8 mg | — |
| Comparator | epoetin alfa | Protein / enzyme biologic | — | — |